624 related articles for article (PubMed ID: 33232785)
21. Effect of a Nutritional Intervention on the Intestinal Microbiota of Vertically HIV-Infected Children: The Pediabiota Study.
Sainz T; Gosalbes MJ; Talavera-Rodríguez A; Jimenez-Hernandez N; Prieto L; Escosa L; Guillén S; Ramos JT; Muñoz-Fernández MÁ; Moya A; Navarro ML; Mellado MJ; Serrano-Villar S
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32708743
[TBL] [Abstract][Full Text] [Related]
22. Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies.
Shabbir U; Arshad MS; Sameen A; Oh DH
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33669988
[TBL] [Abstract][Full Text] [Related]
23. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
24. An updated overview on the relationship between human gut microbiome dysbiosis and psychiatric and psychological disorders.
Borrego-Ruiz A; Borrego JJ
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110861. PubMed ID: 37690584
[TBL] [Abstract][Full Text] [Related]
25. Direct Modulation of the Gut Microbiota as a Therapeutic Approach for Alzheimer's Disease.
Wang Y; Dykes GA
CNS Neurol Disord Drug Targets; 2022; 21(1):14-25. PubMed ID: 34365962
[TBL] [Abstract][Full Text] [Related]
26. Microbiota-Gut-Brain Axis: Pathophysiological Mechanism in Neuropsychiatric Disorders.
Shin C; Kim YK
Adv Exp Med Biol; 2023; 1411():17-37. PubMed ID: 36949304
[TBL] [Abstract][Full Text] [Related]
27. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease.
Suk KT; Kim DJ
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767
[TBL] [Abstract][Full Text] [Related]
28. Narrative review on potential role of gut microbiota in certain substance addiction.
Qin C; Hu J; Wan Y; Cai M; Wang Z; Peng Z; Liao Y; Li D; Yao P; Liu L; Rong S; Bao W; Xu G; Yang W
Prog Neuropsychopharmacol Biol Psychiatry; 2021 Mar; 106():110093. PubMed ID: 32898589
[TBL] [Abstract][Full Text] [Related]
29. Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.
Liu S; Gao J; Zhu M; Liu K; Zhang HL
Mol Neurobiol; 2020 Dec; 57(12):5026-5043. PubMed ID: 32829453
[TBL] [Abstract][Full Text] [Related]
30. Antibiotic-associated Gut Dysbiosis.
Ramakrishna BS; Patankar R
J Assoc Physicians India; 2023 Nov; 71(11):62-68. PubMed ID: 38720499
[TBL] [Abstract][Full Text] [Related]
31. Pancreatic Cancer and Gut Microbiome-Related Aspects: A Comprehensive Review and Dietary Recommendations.
Sobocki BK; Kaźmierczak-Siedlecka K; Folwarski M; Hawryłkowicz V; Makarewicz W; Stachowska E
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959977
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic and Modulation of Microbiota: A New Paradigm?
Rizzatti G; Ianiro G; Gasbarrini A
J Clin Gastroenterol; 2018; 52 Suppl 1, Proceedings from the 9th Probiotics, Prebiotics and New Foods, Nutraceuticals and Botanicals for Nutrition & Human and Microbiota Health Meeting, held in Rome, Italy from September 10 to 12, 2017():S74-S77. PubMed ID: 29912755
[TBL] [Abstract][Full Text] [Related]
33. Hidden Role of Gut Microbiome Dysbiosis in Schizophrenia: Antipsychotics or Psychobiotics as Therapeutics?
Munawar N; Ahsan K; Muhammad K; Ahmad A; Anwar MA; Shah I; Al Ameri AK; Al Mughairbi F
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299291
[TBL] [Abstract][Full Text] [Related]
34. The Microbiota-Gut-Brain Axis.
Cryan JF; O'Riordan KJ; Cowan CSM; Sandhu KV; Bastiaanssen TFS; Boehme M; Codagnone MG; Cussotto S; Fulling C; Golubeva AV; Guzzetta KE; Jaggar M; Long-Smith CM; Lyte JM; Martin JA; Molinero-Perez A; Moloney G; Morelli E; Morillas E; O'Connor R; Cruz-Pereira JS; Peterson VL; Rea K; Ritz NL; Sherwin E; Spichak S; Teichman EM; van de Wouw M; Ventura-Silva AP; Wallace-Fitzsimons SE; Hyland N; Clarke G; Dinan TG
Physiol Rev; 2019 Oct; 99(4):1877-2013. PubMed ID: 31460832
[TBL] [Abstract][Full Text] [Related]
35. Microbiome Disturbances and Autism Spectrum Disorders.
Rosenfeld CS
Drug Metab Dispos; 2015 Oct; 43(10):1557-71. PubMed ID: 25852213
[TBL] [Abstract][Full Text] [Related]
36. Autism Spectrum Disorders and the Gut Microbiota.
Fattorusso A; Di Genova L; Dell'Isola GB; Mencaroni E; Esposito S
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823414
[TBL] [Abstract][Full Text] [Related]
37. Targeting the microbiota in pharmacology of psychiatric disorders.
Pascale A; Marchesi N; Govoni S; Barbieri A
Pharmacol Res; 2020 Jul; 157():104856. PubMed ID: 32389857
[TBL] [Abstract][Full Text] [Related]
38. Impact of gut microbiota on neurological diseases: Diet composition and novel treatments.
Larroya-García A; Navas-Carrillo D; Orenes-Piñero E
Crit Rev Food Sci Nutr; 2019; 59(19):3102-3116. PubMed ID: 29870270
[TBL] [Abstract][Full Text] [Related]
39. Antibiotics, gut microbiota, and Alzheimer's disease.
Angelucci F; Cechova K; Amlerova J; Hort J
J Neuroinflammation; 2019 May; 16(1):108. PubMed ID: 31118068
[TBL] [Abstract][Full Text] [Related]
40. The brain-gut-microbiota interplay in depression: A key to design innovative therapeutic approaches.
Varesi A; Campagnoli LIM; Chirumbolo S; Candiano B; Carrara A; Ricevuti G; Esposito C; Pascale A
Pharmacol Res; 2023 Jun; 192():106799. PubMed ID: 37211239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
